Physician profile
Candace Labonte
NPI 1598373680
$2,002.53
in general payments reported to CMS, 2019-2025
18 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2023: $647 · 2024: $1,053 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.64 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $327.71 | 2021-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Dexcom, INC. | $299.07 | 2023-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $263.23 | 2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.24 | 2024-2025 | Jardiance, Synjardy, Tradjenta |
| Phathom Pharmaceuticals, INC. | $174.46 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $137.84 | 2023-2024 | Mounjaro, Trulicity |
| Amgen INC. | $106.74 | 2023-2025 | Otezla, Prolia, Evenity |
| Exact Sciences Corporation | $105.26 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $86.32 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.30 | 2023-2024 | |
| Abbvie INC. | $66.48 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $63.76 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $38.03 | 2021 | |
| Novo Nordisk INC | $22.86 | 2025 | Ozempic |
| Boston Scientific Corporation | $19.83 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $17.06 | 2023 | Symtuza |
| Amarin Pharma, INC. | $12.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Labonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.